| Trial period | ||||||
---|---|---|---|---|---|---|---|
Enrolment | Allocation to intervention | Post-allocation | |||||
Time point | 0 weeks | 2–3 weeks | 4 weeks | 8 weeks | 12 weeks | 26 weeks | Post-26 weeks |
Enrolment | X | Â | Â | Â | Â | Â | Â |
    Eligibility screen | X |  |  |  |  |  |  |
    Informed consent | X |  |  |  |  |  |  |
    DNA collection | X |  |  |  |  |  |  |
    Allocation to intervention |  | X |  |  |  |  |  |
Interventions | |||||||
    Antidepressant prescribing report |  | X |  |  |  |  |  |
    Full clinical PGx report |  |  |  |  |  |  | X |
Assessments | |||||||
    Demographics | X |  |  |  |  |  |  |
    PHQ-9 | X |  | X | X | X | X |  |
    FISBER | X |  | X | X | X | X |  |
    AQoL-4D | X |  |  |  | X | X |  |
    MARS-5 | X |  | X | X | X | X |  |
    COVID-19 QoL and Mental Health Impact Scale |  |  |  |  |  | X |  |
    Resource use questionnaire | X |  |  |  | X | X |  |
    GP record audit |  |  |  |  |  | X |  |
    MBS and PBS data |  |  |  |  |  |  | X |